Evaluation of the elimination of Alendronate in hemodialysis patients
Not Applicable
- Conditions
- osteoporosis
- Registration Number
- JPRN-UMIN000027182
- Lead Sponsor
- Makita general hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with severe liver disease 2) Patients with severe heart disease 3) Patients may be pregnant 4)Patients with active infections 5) Patients who have bad oral consitions 6) Patients who are thought to be inappropriate for this study by physician.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the elimination of alendronate calculated by the difference of concentration between the arterial line and the venous line.
- Secondary Outcome Measures
Name Time Method